Mallinckrodt Puts Up $2.3B For PE-Backed Lung Drug Outfit
Mallinckrodt PLC on Thursday added to a growing list of Big Pharma deals with a $2.3 billion agreement to buy private equity-backed Ikaria Inc., a move that will broaden its specialty...To view the full article, register now.
Already a subscriber? Click here to view full article